Skip to content

CeriBell, Inc. CBLL Price / sales

Price / sales at other companies

IAR
Integra LifeSciencesIART
0.4×-0.6×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
6.6×-3.5×
iRadimed logo
iRadimedIRMD
14.3×+5.4×
Teladoc Health logo
Teladoc HealthTDOC
0.4×-0.2×
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
17.2×
Cerence Inc. logo
Cerence Inc.CRNC
0.9×-0.4×

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

Based on the most recent quarter.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s price / sales?
CeriBell, Inc. (CBLL) reported price / sales of 7.3× in Q1 2026.
How has CeriBell, Inc.'s price / sales changed year-over-year?
CeriBell, Inc.'s price / sales decreased by 24.7% year-over-year, from 9.6× to 7.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.